Abstract:Relative quantification of N-glycoproteomes shows great promise for the discovery of candidate biomarkers and therapeutic targets. The traditional protocol for quantitative analysis of glycoproteomes is usually off-line performed, and suffers from long sample preparation time, and the risk of sample loss or contamination due to manual manipulation. In this study, a novel integrated sample preparation platform for quantitative N-glycoproteome analysis was established, with combination of online N-glycopeptide capture by a HILIC column, sample buffer exchange by a N2-assisted HILIC-RPLC interface, deglycosylation by a hydrophilic PNGase F immobilized enzymatic reactor (hIMER) and solid dimethyl labeling on a C18 precolumn. To evaluate the performance of such a platform, two equal aliquots of immunoglobulin G (IgG) digests were sequentially pretreated, followed by MALDI-TOF MS analysis. The signal intensity ratio of heavy/light (H/L) labeled deglycosylated peptides with the equal aliquots was 1.00 (RSD=6.2%, n=3), much better than those obtained by the offline protocol, with H/L ratio as 0.76 (RSD=11.6%, n=3). Additionally, the total on-line sample preparation time was greatly shortened to 160 min, much faster than that of offline approach (24h). Furthermore, such an integrated pretreatment platform was successfully applied to analyze the two kinds of hepatocarcinoma ascites syngeneic cell lines with high (Hca-F) and low (Hca-P) lymph node metastasis rates. For H/L labeled Hca-P lysates with the equal aliquots, 99.6% of log2 ratios (H/L) of quantified glycopeptides ranged from -1 to 1, demonstrating high accuracy of the developed sample preparation strategy. By triplicated analysis of glycopeptides and non-glycopeptides of Hca-F and Hca-P lysates, 43 up-regulated and 30 down-regulated (Hca-F/P) N-glycosylation sites, and 11 significantly changed N-glycoproteins were successfully quantified, and most of them were related to tumorigenesis and tumor metastasis. All these results demonstrate the developed integrated N-glycoprotein pretreatment platform is of great power for the accurate, precise and high-throughput analysis of N-glycoproteomes.

A Streamlined Strategy for Rapid and Selective Analysis of Serum N-glycome.

Sensitive <i>N</i>-Glycopeptide Profiling of Single and Rare Cells Using an Isobaric Labeling Strategy without Enrichment

A simple integrated system for rapid analysis of sialic-acid-containing N-glycopeptides from human serum.

Rapid N-Glycan Profiling of Serum and Plasma by a Novel Slide-Based Imaging Mass Spectrometry Workflow

Automated Intact Glycopeptide Enrichment Method Facilitating Highly Reproducible Analysis of Serum Site-Specific N-Glycoproteome

Sample preparation for mass spectrometric analysis of human serum N-glycans using hydrophilic interaction chromatography-based solid phase extraction.

Proteomics Analysis of O-GalNAc Glycosylation in Human Serum by an Integrated Strategy

An Integrated Sample Pretreatment Platform for Quantitative N-glycoproteome Analysis with Combination of On-Line Glycopeptide Enrichment, Deglycosylation and Dimethyl Labeling.

Microwave-Assisted Deglycosylation for Rapid and Sensitive Analysis of N-Glycans Via Glycosylamine Derivatization

Targeted glycomics by selected reaction monitoring for highly sensitive glycan compositional analysis.

Highly Efficient N-Glycoproteomic Sample Preparation by Combining C-18 and Graphitized Carbon Adsorbents

Monolithic Capillary Column Based Glycoproteomic Reactor for High-Sensitive Analysis of N-Glycoproteome

Glycans, Glycosite, and Intact Glycopeptide Analysis of N-Linked Glycoproteins Using Liquid Handling Systems

Development of a 96-Well Plate Sample Preparation Method for Integratedn- Ando-Glycomics Using Porous Graphitized Carbon Liquid Chromatography-Mass Spectrometry

Serum IgG N-glycans Enable Early Detection and Early Relapse Prediction of Colorectal Cancer.

Highly Specific Purification of N-glycans Using Phosphate-Based Derivatization As an Affinity Tag in Combination with Ti(4+)-SPE Enrichment for Mass Spectrometric Analysis.

Integrated Pipeline of Isotopic Labeling and Selective Enriching for Quantitative Analysis of N-Glycome by Mass Spectrometry.

High throughput human plasma N-glycan analysis using DNA analyzer and multivariate analysis for biomarker discovery

N-glycans Released from Glycoproteins Using a Commercial Kit and Comprehensively Analyzed with a Hypothetical Database

Glycomic Analysis by Glycoprotein Immobilization for Glycan Extraction and Liquid Chromatography on Microfluidic Chip.

Development of an Integrated Platform for the Simultaneous Enrichment and Characterization of N- and O-Linked Intact Glycopeptides.